SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medi-Caps informs about disclosure

16 Apr 2022 Evaluate

With reference to the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 and pursuant to BSE Circular No. LIST/COMP/59/2019-20 dated 3rd March, 2020 read with LIST/COMP/05/2019-20 dated 11th April, 2019 with regard to fund raising by issuance of debt securities by large entities, Medi-Caps has confirmed that the Company is not falling under Large Corporate category as on 31st March, 2022 as per the framework provided in the said circular. Hence the provisions of above said circular are not applicable to the Company.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

29.85 -1.02 (-3.30%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×